Search results “New cancer research stanford ucsf”
Ucsf Prostate Cancer - What's New In Prostate Cancer Treatment? | Dana-Farber Cancer Institute
Ucsf Prostate Cancer - What's New In Prostate Cancer Treatment? | Dana-Farber Cancer Institute. For alternative option go to https://wp.me/p9xQ8n-55 ucsf prostate cancer - prostate cancer overview. ucsf prostate cancer radiation Or poster at the annual UCSF Prostate Cancer research retreat 2013 UCSF Prostate Cancer Retreat ucsf prostate cancer nomogram The authors thank Jeanette Broering, Hazel Dias, Alex Ignatov, Sarah Joost and Frank Stauf for operating and managing the UCSF Urologic Oncology Outcomes Database and Nannette Perez for supporting the UCSF prostate cancer active surveillance cohort The hallmark of research in the UCSF Prostate Cancer Program is innovative scientific approaches to important problems in prostate cancer. Prostate cancer decisions: mayo clinic radio. Esmo 2017: prostate cancer highlights. Lifestyle and Diet May Stop or SuMMarY heaLthY proState CaNCer diet 23 frequently asked Questions University of California, San Francisco Patient Advocates Stan Rosenfeld, ucsf prostate cancer diet. He is the leader of the Genitourinary Medical Oncology Program and an investigator with the UCSF Prostate Cancer Program. The hallmark of research in the UCSF Prostate Cancer Program is innovative scientific approaches to important problems in prostate cancer. 2015 UCSF Prostate Cancer Program Retreat. The authors thank Jeanette Broering, Hazel Dias, Alex Ignatov, Sarah Joost and Frank Stauf for operating and managing the UCSF Urologic Oncology Outcomes Database and Nannette Perez for supporting the UCSF prostate cancer active surveillance cohort. Search Results For: ucsf prostate cancer active surveillance. Poster presentation, UCSF Prostate Cancer Retreat, San Francisco, CA, on May 23, 2011 PROCEEDINGS: 1993 Wyeth Pediatrics: Pediatric and adolescent gynecology: a challenge for the '90s. 3/01: UCSF Prostate Cancer Retreat, “Interrupting assembly of nuclear hormone receptor transcriptional activation complexes: Implications for drug development”. Place Clinical Science Poster, UCSF Prostate Cancer Retreat. June 16, 2010, Josh Stuart, UCSF Prostate Cancer Retreat. 6/01-5/02: Co-PI (with Robert Fletterick), UCSF Prostate Cancer Research Program, “Novel. Best Poster presentation award at the Annual UCSF prostate Cancer Research Retreat-2016. Or poster at the annual UCSF Prostate Cancer research retreat. 2011 UCSF Prostate Cancer Research Retreat. 5 Million for UCSF Prostate Cancer Research. Search Results For: ucsf prostate cancer radiation. Expert opinions in prostate cancer brazil 2017. What's new in prostate cancer treatment? Patients with advanced prostate cancer are currently treated with combinations and sequences of immunotherapies hormonal approaches and chemotherapy. Freedland presented "nutrition and prostate cancer: what we think we know and what we actually know" at the 22nd annual scottsdale prostate cancer symposium on thursday march 16 2017. Nutrition and prostate cancer what we think we know and what we actually know. Body rig research highlights - treatment of prostate cancer at ucsf using different tools and techniques such as hifu prostate hyperthermia micropet / ct images of psma and hyperpolarized c-13 mr. Localized prostate cancer: progress toward personalized care. Rethinking prostate cancer at ucsf with matthew cooperberg, md. In the era of prostate cancer screening mortality rates have fallen 40 percent. In the era of prostate cancer screening mortality rates have fallen 40 percent. In the era of prostate cancer screening mortality rates have fallen 40 percent. Viewing prostate cancer aggressiveness in a unique way. #UcsfProstateCancer ucsf prostate cancer treatment, ucsf prostate cancer diet, ucsf prostate cancer clinical trials, stanford prostate cancer, ucsf prostate cancer program, ucsf lung cancer doctors, ucsf prostatectomy Reference: https://youtu.be/dU-E-_axrZc https://www.youtube.com/playlist?list=PLLmSMVj8_5y8Mt-0eXZtUt67k3ad2OGOW https://en.wikipedia.org/wiki/Prostate_cancer https://en.wikipedia.org/wiki/University_of_California,_San_Francisco https://www.youtube.com/watch?v=oU-BAjUppfU
Views: 2589 Best Tongkat Ali
UCSF - Helen Diller Family Comprehensive Cancer Center
Learn more about how UCSF's expert team is advancing cancer care and research worldwide.
The Future of Machine Learning in Clinical Imaging
(Visit: http://www.uctv.tv/) 0:15 - Intro to Machine Learning - Marc Kohli 15:51 - Training Computers to "Look" at X-rays Using Deep Learning - Andrew Taylor 36:33 - Artificial Intelligence and the Future of Radiology - John Mongan 55:16 - Audience Questions Machine learning can augment clinical and research activities in many ways. Find out the latest on the future of machine learning in clinical imaging. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [11/2017] [Show ID: 32933]
Cancer Genetics and Precision Cancer Therapy - Life Sciences Forum
Please join us as MITCNC hosts the second Bay Area with/in/sight lecture series from the David H. Koch Institute for Integrative Cancer Research at MIT. We invite you to enjoy the networking reception, mingle with fellow guests and scientists, and join us for a series of informative talks about recent exciting progress in the areas of cancer genetics and new treatments based on our understanding of cancer genes. The event will showcase research from MIT's Dr. Tyler Jacks, PhD, David H. Koch Professor of Biology, Investigator at the Howard Hughes Medical Institute, and Director of the Koch Institute for Integrative Cancer Research. Professor Jacks will discuss work from his laboratory on the development of novel therapeutic strategies that target common genetic alterations in many human cancers. Dr. Jacks will be joined by Dr. Kevin Shannon, MD, who is the Roma and Marvin Auerback Distinguished Professor in Pediatric Oncology at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr. Shannon, a physician-scientist, will discuss the challenges and opportunities of new cancer medicines from a clinical perspective. Rounding out the program will be Dr. Jeffrey Settleman, PhD. Dr. Settleman is Senior Director of Discovery Oncology at Genentech. He will present research from his own laboratory at Genentech as well as review new cancer therapeutic programs at the company. The panel discussion will be moderated by Dr. Laura D. Attardi, PhD, an Associate Professor in the Departments of Radiation Oncology & Genetics, at Stanford University School of Medicine.
Precision Medicine For Belatacept
(Visit: http://www.uctv.tv/) Minnie Sarwal, MD, FCRP, DCH, PhD. Professor, Department of Surgery, UCSF. Jun Shoji, MD. Assistant Professor, Department of Medicine, UCSF. Recorded on 05/18/2018. Series: "UCSF Transplant Update" [9/2018] [Professional Medical Education] [Show ID: 33827]
The Role of Technology, Data and Innovation in Improving Global Cancer
Panel: “The Role of Technology, Data and Innovation in Improving Global Cancer” Ami Bhatt, MD, PhD, Stanford University (Moderator) Megan Huchko, MD, MPH, UCSF Eduardo Zambrano, MD, MSC, Stanford University Sherry Wren, MD, Stanford University Tracy Sherertz, MD, UCSF Kris Sankaran, Stanford University 4th Annual Symposium on Global Cancer Research Hilton San Francisco Union Square April 8, 2016
Views: 28 GlobalOnc
Understanding the Basics of Clinical Oncology from Diagnosis to Treatment
(Visit: http://www.uctv.tv/) Dr. Andrew Ko, UCSF Comprehensive Cancer Center, provides definitions and terms used in cancer diagnosis and treatment. He explores the process of diagnosis from biopsies to imaging and how staging is established. He also discusses the multimodality approach to treatment which typically includes surgical oncology, medical oncology and radiation oncology. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [10/2013] [Health and Medicine] [Show ID: 25630]
Renal Cell Carcinoma
(Visit: http://www.uctv.tv/) In the United States, there are over 60,000 new diagnoses and nearly 14,000 deaths from kidney cancer each year. Dr. Won Kim reviews the epidemiology of kidney cancer (including established risk factors), the biology and pathophysiology of kidney cancer, treatment options for localized disease, and the role of systemic therapy in the treatment of advanced, metastatic disease. He also discusses the current and future role of immunotherapy in kidney cancer. Recorded on 07/15/2014. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2014] [Health and Medicine] [Show ID: 28502]
Accelerate Research for a Cancer-Free World!
Researchers at UC San Francisco are leading the way in identifying new pathways to treating many types of cancer. You can be a part of this movement by contributing directly to the UCSF Helen Diller Family Comprehensive Cancer Center. Give today at http://proj.at/1anxbig
Stanley Falkow (Stanford University) Part 2: Helicobacter pylori and Gastric Cancer
https://www.ibiology.org/microbiology/host-pathogen-interactions-human-disease/#part-2 Lecture Overview Ninety percent of the cells humans carry are microbes. Only a few of the bacteria we encounter are pathogenic and can cause disease. Pathogens possess the inherent ability to cross anatomic barriers or breach other host defenses that limit the microbes that make up our normal flora. A significant part of human evolution has gone into developing ways to thwart microbial intrusion. In turn, microbes have come up with clever ways to avoid and circumvent host defenses but human — microbe interactions is still a "Work in Progress." When we study pathogens we learn as much about ourselves as we do about them. Helicobacter pylori lives in the human stomach. It causes gastritis, ulcer disease and even gastric cancer. Some H. pylori can inject a protein, CagA, into gastric epithelial cells. CagA interacts with the tight junctions that bind cells together and with signaling molecules affecting motility and proliferation. CagA is associated with ulcer disease and cancer but we don't understand how it works to favor malignancy. Not long ago in history most humans carried H. pylori ; the incidence of carriage and gastric cancer is dropping but there is evidence that this microbe also had a protective effect on human health.
Views: 15281 iBiology
The Science and Art of Integrative Medicine
(Visit: http://www.uctv.tv/) Explore the research behind the science of integrative medicine with Dr. Kevin Barrows, UCSF Department of Family and Community Medicine and Medical Director, Osher Center for Integrative Medicine. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [11/2013] [Health and Medicine] [Show ID: 25721]
Needle Steering using AcuBot for Brachytherapy - UC Berkeley, JHU, Stanford, UNC, UCSF (HD)
AcuBot1-RND demonstration - UC Berkeley Automation Sciences Lab demonstrates multiple needle insertions into tissue phantom for applications to robotic brachytherapy and robotic-assisted surgery. The tissue phantom consists of an obstacle (top ball) and a target (bottom ball). The goal of the demo is to reach various regions of the target using only a few entry points at the surface and avoiding the obstacle. The demo is executed entirely without human intervention. This is a demonstration of the ability of the robot and algorithms to deliver treatment for prostate cancer Brachytherapy. AcuBot1-RND designed and constructed by Dan Stoianovici at Johns Hopkins University.
Views: 1243 Animesh Garg
Going to UCSF? Consider Medical Research
https://www.labtv.com/Home/Profile?researcherId=1269 Meet Gideon Rothschild, a Post-Doc in the Frank Lab at the University of California, San Francisco. Gideon is looking to better understand how human brains learn material and generate memories. His research will be applicable to a number of diseases and conditions that relate to learning and memory. To learn more about Gideon, visit https://www.labtv.com/Home/Profile?researcherId=1269
Views: 12721 LabTV
Gynecologic Cancer Treatment
(Visit: http://www.uctv.tv/) Explore treatments, other than surgery, to treat gynecologic cancer: radiation, cytotoxic chemotherapy, targeted treatments, and immunotherapy. Recorded on 03/21/2017. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [6/2017] [Health and Medicine] [Show ID: 32079]
Top 10 Best Cancer
Treatment Hospitals in The World
Here are the top 10 Best Cancer Treatment Hospitals in The World 👇👇👇👇👇👇👇👇 10. Stanford Health Stanford Hospital, Stanford, California: This hospital was founded in 1968 and it is located in the California. It is a well known hospital for treatment of cancer diseases. This hospital has well experienced doctors, nurses, staff that also provides many other diseases treatment. It provides treatment of heart diseases, organ transplantation, brain diseases, cancer and various other surgeries and therapies. This hospital has yearly 40 thousand room visits. This hospital can treat 20 thousand patients yearly. This hospital also provides helicopter facility to take the patient to the hospital with only one call. 9. UCSF Medical Center, San Francisco: It is one of the leading hospital and institute in research in San Francisco, California. This hospital provides treatment for all the complex diseases. The medical institute id affiliated with the university of California and it is located in the Parnassus Heights, Mission Bay. This hospital has been ranked in the top 10 in various disease treatments including diabetes, neurology, gynecology, cancer and many more. From the Chuck Feeney, this hospital has been gifted with a donation of $100 million. This hospital is very famous for its advanced treatment of cancer. The doctors also provide awareness of cancer by providing the right information to the patients. This hospital can treat 500 patients at one time. This hospital can treat 14 different types of cancers and other major diseases. 8. Massachusetts General Hospital, Boston: It is 2nd biggest hospitals in the England and it is very famous hospital to treat cancer diseases. The research center of this hospital is located in the West End neighborhood of Boston, Massachusetts. This hospital can treat thousand patients at one time. It offers cancer treatment nationally and internationally. This hospital provides high quality and best services to cancer patient and also provides medicines to the patient. This hospital also uses chemotherapies and radio therapies to remove cancer from every body part of the patient. This hospital can treat various cancers, including bone, breast, blood, bladder and many more. 7. UCLA Medical Center, Los Angeles: This hospital was founded in 1955 and it is located in the Los Angeles, CA. This hospital had already 23 thousand entries in surgical treatment. This hospital treat 10 thousand patients annually and 15 thousand surgeries. It is also a teaching institute. This hospital is also ranked in adult and children special treatment. This hospital also known as the Ronald Reagan Medical Center. The department of this hospital works 24 hours to treat various diseases. This hospital also uses latest and new technology to treat various types of cancer diseases. This hospital also has very experienced doctors, that prevent the further possibility of cancer and control it at the first stage. This hospital provides various treatments at a reasonable rate. 6. Johns Hopkins Hospital, Baltimore: It is one of the most famous hospitals in the world. It is one of the best institute and hospital for treatment of cancer. This hospital is located in the Baltimore, USA. It has also well experienced and qualified doctors and trainers. The hospital also provides huge types of treatment plans for the patients. The doctors and research team are given different tasks to diagnose and treat cancer from anyone’s life. With the new and advanced technique, the doctors can make it possible to cure the Genetic abnormalities and also the cancer diseases. It helps to treat various types of cancer including, colon, gyne, breast, head cancer and much more. It also provides various programs to treat various diseases and cancer. This hospital also provides another treatment, including stem cell transplantation, DNA repair, regulating cell cycle and much more. 5. Seattle Cancer Care Alliance or the University of Washington Medical Center: SCCA is located in the Seattle, Washington. This hospital was started in 1998 by the Fred Hutchinson. This hospital has well experienced surgeons, doctors, oncologists and other faculty. In 2014, this hospital treat 7 thousand patients. The doctors help to treat many cancers, including breast cancer, lung, colon and many other cancers successfully. In 2015, this hospital has been named in the list of 5 best cancer treatment hospitals. This hospital also performed the transplant program of the Fred Hutch Bone Marrow. The vice president of the hospital is Norm Hubbard. This hospital uses 20 different methods to treat cancer and it also provides transplantation and bone marrow operation facility. This hospital also has its branches in various places of the Washington state. 4. Dana Farber and Brigham and Women’s Cancer Center, Boston: This hospital is located in the Boston, Massachusetts and it is founded in 1997. It helps to treat a wide variety of cancer diseases.
Views: 930 WORLD WiNNER360
Atrial Fibrillation for the Interested Layperson
(Visit: http://www.uctv.tv/) UCSF cardiologist Dr. Gregory Marcus covers the basic mechanisms underlying atrial fibrillation - an irregular, often rapid heart rate. He discusses the consequences of the disease, and the various therapies available for treatment. Gregory is the Director of Clinical Research in the Division of Cardiology at UCSF. Recorded on 06/03/2015. Series: "UCSF Osher Center for Integrative Medicine presents Mini Medical School for the Public" [9/2015] [Health and Medicine] [Show ID: 29727]
Bench to Bedside: Autism Spectrum Disorder, part 2 - From Genes to Pathology - Matthew State (UCSF)
https://www.ibiology.org/human-disease/autism-spectrum-disorder/#part-2 Dr. Bryan King introduces the autism spectrum disorder (ASD), and Dr. Matthew State overviews the hunt for genes associated with autism. Talk Overview: In the first lecture, Dr. Bryan King introduces the autism spectrum disorder (ASD) and defines the clinical criteria that characterizes ASD. Although there is no universal drug that is used to treat ASD, there are multiple medications used in the setting of autism. King outlines the different drugs used to treat the core behavioral features of autism as well as psychiatric disorders associated with autism (e.g. ADHD and anxiety), and discusses the challenges and problems with designing clinical trials to study drugs to treat ASD, specifically with the heterogeneity of the ASD population. In the second lecture, Dr. Matthew State overviews the hunt for genes associated with autism and explains how studying de-novo rare mutations in the germline has advanced the understanding of the genetics of autism spectrum disorder (ASD). Studying a cohort of families with one affected individual and one unaffected sibling, they were able to map multiple genes involved in ASD. Because of the complexity of the developing brain, the same gene could act upon different regions of the brain at different times during development. Therefore, after identifying genes associated with ASD, they characterized the region and time during development where these genes are expressed and more likely to have an effect that is associated with ASD. Speaker Biography: Dr. Matthew State is the Oberndorf Family Distinguished Professor and Chair of Psychiatry at the University of California, San Francisco and President of the Langley Porter Psychiatric Hospital and Clinics. He obtained his bachelor’s degree from Stanford University (1984) and received his medical degree from Stanford Medical School (1991). He continued his medical training at the UCLA Neuropsychiatric Institute specializing in Child Psychiatry, and completed a doctorate degree in genetics at Yale University (2001). State was a faculty member at Yale University from 2001 to 2013. In 2014, he joined the faculty at UCSF where his laboratory studies the genetics and genomics of developmental neuropsychiatric disorders, with a particular interest in Autism Spectrum Disorder and Tourette Disorder. For his scientific contributions, State received the Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine (2017), and was elected member of the National Academy of Medicine (2014). Learn more about State’s research at his lab website: http://www.mstatelab.com/
Views: 651 iBiology
Prof. Donald I. Abrams MD - Cannabis and Cancer Care
Donald I. Abrams, MD. is chief of the Hematology-Oncology Division at San Francisco General Hospital and a Professor of Clinical Medicine at the University of California San Francisco. He has an Integrative Oncology consultation practice at the UCSF Osher Center for Integrative Medicine. He received an A.B. in Molecular Biology from Brown University in 1972 and graduated from the Stanford University School of Medicine in 1977. After completing an Internal Medicine residency at the Kaiser Foundation Hospital in San Francisco, he became a fellow in Hematology/Oncology at the Cancer Research Institute of the University of California, San Francisco in 1980. He was one the original clinician/investigators to recognize and define many early AIDS-related conditions. He has long been interested in clinical trials of complementary and alternative medicine interventions for HIV/AIDS and cancer, including evaluations of medicinal Cannabis. In 1997 he received funding from the National Institute on Drug Abuse to conduct clinical trials of the short-term safety of cannabinoids in HIV infection. Subsequently he was granted funds by the University of California Center for Medicinal Cannabis Research to continue studies of the effectiveness of cannabis in a number of clinical conditions. He completed a placebo-controlled study of smoked cannabis in patients with painful HIV-related peripheral neuropathy as well as a study evaluating vaporization as a smokeless delivery system for medicinal. He conducted an NIDA-funded trial investigating the possible pharmacokinetic interaction between vaporized cannabis and opioid analgesics in patients with chronic pain. He is now conducting an NIH-funded trial investigating vaporized cannabis in patients with Sickle Cell disease. He co-authored the chapter on “Cannabinoids and Cancer” in the Oxford University Press Integrative Oncology text that he co-edited with Andrew Weil. He co-edits the NCI PDQ CAM Cannabinoids and Cancer website. For further credentials and a summary of the scientific evidence to be presented to the court, please see Fields of Green for ALL’s Expert Witness page.
Views: 2132 Dagga Couple
Early Diagnosis of Cancer: Imaging at the Molecular Level
(May 25, 2010) Dr. Sam Gambhir M.D., PhD., Professor of Nuclear Medicine at the Stanford University Medical School, discusses how nuclear medicine and different imaging techniques can be used to diagnose cancer and other diseases at early stages at the molecular level. During the final quarter of the Stanford Mini Med School, some of the most timely and important topics in contemporary medicine and the biosciences are addressed. Stanford Mini Med School is a series arranged and directed by Stanford's School of Medicine and presented by the Stanford Continuing Studies program. Stanford University: http://www.stanford.edu Stanford Medical School: http://med.stanford.edu/ Stanford Continuing Studies: http://continuingstudies.stanford.edu/ Stanford University Channel on YouTube: http://www.youtube.com/stanford
Views: 10481 Stanford
UCSF Radiology: Breast Cancer Imaging and Clinical Trials at UCSF
UCSF Radiologist Dr Bonnie Joe describes how UCSF not only offers breast cancer imaging, but breast cancer clinical trials as well.
Views: 131 UCSF Imaging
Advances in NET Treatment
With Dr. Pamela Kunz, Stanford, Dr. Brenda Visser, Stanford, Dr. Arthur Sung, Stanford, and Dr. Emily Bergsland, UCSF
Views: 1656 Caring4Carcinoid
Welcome and Opening Remarks - 4th Annual Symposium on Global Cancer Research
Welcome and Opening Remarks Lisa Stevens, PhD, Deputy Director, Center for Global Health, National Cancer Institute (NCI), National Institutes of Health, U.S. Department of Health and Human Services Bev Mitchell, MD, Director, Stanford Cancer Institute Alan Ashworth, PhD, FRS, President, UCSF Helen Diller Family Comprehensive Cancer Center 4th Annual Symposium on Global Cancer Research Hilton San Francisco Union Square April 8, 2016
Views: 35 GlobalOnc
CLOSING REMARKS - 4th Annual Symposium on Global Cancer Research
Ami Bhatt, MD, PhD, Stanford University Katherine Van Loon, MD, MPH, UCSF 4th Annual Symposium on Global Cancer Research Hilton San Francisco Union Square April 8, 2016
Views: 70 GlobalOnc
NETRF Bay Area NET Patient Education Conference - 11 Clinical Trials
NETRF Bay Area NET Patient Education Conference Stanford Cancer Center & NET Research Foundation 2.4.2017 www.netrf.org Emily Bergsland, MD Professor of Clinical Medicine, Helen Diller Family Comprehensive Cancer Center, UCSF Dr. Emily Bergsland is a professor of clinical medicine at the University of California, San Francisco (UCSF). She holds the Ernest Rosenbaum, MD Endowed Chair in Medical Oncology and is the director of the Hematology/Oncology Fellowship Program. Dr. Bergsland earned her medical degree from the University of Minnesota and performed her internal medicine training at UCSF. She subsequently completed a fellowship in Medical Oncology, and a training program in Molecular Medicine, before joining the UCSF faculty in 1998. Dr. Bergsland is a gastrointestinal oncologist with a clinical research effort focused on novel therapies for neuroendocrine tumors. She is co-chair of the Neuroendocrine Tumor Task Force of the National Cancer Institute (NCI) Gastrointestinal Steering Committee, a member of the NCCN Neuroendocrine Tumors Guidelines Panel, and a member of the Board of Directors of the North American Neuroendocrine Tumor Society (NANETS).
Views: 120 NETRF
The Parnassus Integrated Student Clinical Experience (PISCES)
UC San Francisco advances health through education, research, patient care and public service. With seven major sites in the San Francisco Bay Area and Fresno, the UCSF School of Medicine is dedicated to improving human health by accelerating scientific discovery and transforming medical education. The school’s new Bridges curriculum is pioneering a new approach to medical education to prepare physicians for practice in the 21st century. Through mentorship and collaborative learning, students are trained to care for patients, conduct research and contribute vital knowledge to improve our health system. Visit our channel home page: https://www.youtube.com/c/UCSFSchoolofMedicine Subscribe to this channel: https://www.youtube.com/channel/UCprcipiXNXTzJYJfN02rHsA?sub_confirmation=1
The sugar coating on your cells is trying to tell you something | Carolyn Bertozzi | TEDxStanford
In her talk about sugar and cancer, Stanford Chemistry Professor Carolyn Bertozzi tells us why the sugar coating on our cells is crucial to our health and well-being. Unlike the sugar coating on a peanut M&M, she explains, human cells are covered with complex sugars Bertozzi shows us are, “like foliage swaying in the breeze.” The language these sugars are speaking can tell us everything from what blood type we are to whether we have cancer. Carolyn Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry and Professor of Chemical & Systems Biology and Radiology (by courtesy) at Stanford, and an investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree at Harvard and her doctorate at UC Berkeley. After postdoctoral work at UCSF and a professorship at UC Berkeley, she joined the faculty at Stanford coincident with the launch of Stanford ChEM-H. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Views: 55928 TEDx Talks
NETRF Bay Area NET Patient Education Conference - 10 Nuclear Medicine Imaging: Treatment for NETs Pe
NETRF Bay Area NET Patient Education Conference Stanford Cancer Center & NET Research Foundation 2.4.2017 www.netrf.org Thomas Hope, MD Assistant Professor in Residence in the Abdominal Imaging and Nuclear Medicine sections at UCSF and the San Francisco Veterans A airs Medical Center Dr. Thomas Hope is an assistant professor in residence in the Abdominal Imaging and Nuclear Medicine sections at UCSF and the San Francisco Veterans Affairs Medical Center. In 2007, he received his medical degree from Stanford University School of Medicine and he completed a one-year internship at Kaiser Permanente, San Francisco. From 2008-2012, Dr. Hope completed a residency in Diagnostic Radiology at UCSF, followed by a clinical fellowship in Body MRI and Nuclear Medicine from Stanford Medical Center in 2013. Dr. Hope’s main research focus is on novel imaging agents. He is the principle investigator on the Ga-68 DOTA-TOC IND at UCSF and the Ga-68 HBED-CC PSMA IND at UCSF. He plans to combine his interests in MR imaging and nuclear medicine to help further the combined modality, PET/MR.
Views: 1086 NETRF
Redefining Possible: Tailor-Made Treatments for Childhood Leukemia
See how leading-edge science combined with hands-on care at UCSF Benioff Children's Hospitals gives kids and their families new reasons to hope.
Views: 2600 UCSFMedicalCenter
Amanda's Story: UCSF Spine Center
After a long-standing herniated disc became unmanageable, scientist Amanda Woerman, PhD, turned to the UCSF Spine Center for minimally invasive surgery. Four months later she completed her first IRONMAN and today is pain free for the first time in over six years.
Views: 749 UCSF Neurosurgery
Jim Wells and Michelle Arkin(UCSF) Part 1: Introduction to Drug Discovery
https://www.ibiology.org/archive/introduction-drug-discovery-process/ The modern drug discovery process integrates our deepest understanding of the molecular basis for disease with fundamental understanding of how potential drug molecules interact with specific disease targets and the whole organism. These two lectures are intended to give a broad and general introduction to the drug discovery process. Part I focuses on the early stages of drug discovery. We describe the basic stages of the drug discovery process, beginning with how disease targets are identified. We then take you into the laboratory to show you how a popular approach, high throughput screening, is used to identify! compounds that can engage the molecular target or pathway of interest. See more at http://www.ibioseminars.org
Views: 35680 iBiology
Eli Van Allen: Clinical computational oncology for precision medicine
The ability to create increasingly complex genomic data generated directly from patient tumors may impact our understanding of cancer and affect clinical decisions about cancer treatment. As the quantity of genomic data generated from individual cancer patients greatly expands, innovations will be needed to successfully implement large-scale genomics at the point-of-care. These include new ways to 1) interpret large-scale data from individual patients and 2) understand why patients respond (or don't respond) to existing and emerging cancer therapies such as targeted therapies, chemotherapies, and immunotherapies. In this talk, Dr. Van Allen explores how the emerging discipline of clinical computational oncology is powering new approaches for the clinical interpretation of large-scale genomic data and how these data are helping physicians understand why certain patients benefit from cancer therapies when others do not. While still in its infancy, this new field of clinical computational oncology may drive the widespread implementation of precision cancer medicine in the years to come. Eli Van Allen, M.D. A postdoctoral research fellow at the Broad, Eli Van Allen is an Instructor in Medicine at Harvard Medical School and an oncologist at Dana-Farber/Partners Cancer Care, with a focus on genitourinary cancers. His research melds his background in computer science with cancer genomics in order to develop algorithms that analyze and interpret genomic data to help patients. This research is at the front lines of precision cancer medicine, including understanding why resistance develops and identifying targeted therapies for patients. A native of Los Angeles, Eli studied Symbolic Systems, an inter-disciplinary major at Stanford University that applies computer science to other academic disciplines, including linguistics and neuroscience. While at Stanford, he helped found Camp Kesem, a summer camp for children whose parents have cancer. This experience sparked his interest in oncology, and as a medical student, he realized that his talents in computer science could help propel advances in the field. (Eli still volunteers at Camp Kesem, which now has locations throughout the United States.) After graduating from Stanford in 2003, Eli received his M.D. from UCLA, and completed a residency in internal medicine at UCSF before coming to Boston and completing a medical oncology fellowship at the Dana-Farber/Partners Cancer Care program. Copyright Broad Institute, 2015. All rights reserved.
Views: 2237 Broad Institute
The Stanford Man: Dr. Russell Stewart
Meet Dr. Russell Stewart, former Cardinal and NFL tight end who is a musculoskeletal radiology fellow at Stanford Medicine.
Views: 2878 Stanford Athletics
Breast Cancer Genetics, Risk, and Screening
Breast Cancer Genetics, Risk, and Screening Stanford's breast cancer experts share the latest information about: -Breast density and breast cancer risk -Screening recommendations -New breast imaging technologies including tomosynthesis and contract enhanced mammography -Breast cancer genetics Speakers: Sunita Pal, MD, Clinical Assistant Professor, Department of Radiology, Stanford University School of Medicine; Allison W. Kurian, MD, MSc, Assistant Professor of Medicine and Health Research & Policy, Associate Director, Program in Clinical Cancer Genetics Learn more: http://stanfordhealthcare.org/stanford-health-now/health-library-videos/breast-cancer-genetics.html http://stanfordhealthcare.org/medical-conditions/cancer/breast-cancer.html http://stanfordhealthcare.org/medical-clinics/breast-cancer-program.html Visit: http://stanfordhealthcare.org/
Views: 1587 Stanford Health Care
Cancer Cure Testimony 2018
cancer cure high alkaline .. Cure Cancer With Vitamin B17 .. cancer cure orginic foods .. cannabis oil cure cancer 2018 .. New Groundbreaking Cancer Treatments .. New Cancer Treatment 2018
Views: 2799 Captain Nowledge
Liver Resections and Liver Transplants for Neuroendocrine Tumor Patients - Dr. Brendan Visser
On September 25, 2010 the Caring for Carcinoid Foundation held its first Neuroendocrine Tumor Patient Education Conference at Stanford University's Alumni Center in Palo Alto California, USA. This day-long event was attended by over 100 patients and caregivers and featured neuroendocrine tumor experts from Stanford University and UCSF Medical Center.
Views: 1859 Caring4Carcinoid
Topics in Pediatric Dermatology
(Visit: http://www.uctv.tv/) Dr. Kelly M. Cordoro is an adult and pediatric dermatologist at UCSF Medical Center and UCSF Benioff Children's Hospital. She discusses pediatric dermatological conditions such as psoriasis, autoimmune diseases, melanoma, vascular and other birthmarks, laser surgery and other surgical procedures. Series: "UCSF Osher Mini Medical School for the Public" [7/2012] [Health and Medicine] [Show ID: 23808]
Cell Therapy for Cancer: Past, Present and Future
What does cell therapy in cancer look like today, and what will this exploding field look like in the future? This has been a milestone year for cell therapy, with FDA approval of the first adoptive CAR T-cell therapies for acute myeloid leukemia and some large B-cell lymphomas. But there is much more on the horizon. Watch Jeff Bluestone, PhD, president and CEO of the Parker Institute for Cancer Immunotherapy, and Crystal Mackall, MD, center director of the Parker Institute at Stanford Medicine, discuss new approaches, strategies and technologies for cell-based therapies that will continue to transform precision medicine. This talk was recorded at the Precision Medicine World Conference in January 2018 in Silicon Valley.
Esther Gokhale - Sitting: The Good, the Bad, and the Ugly
Sitting is an activity as old as our species. Our ancestors sat to tan hides, weave baskets, and make pottery. The Buddha sat to achieve enlightenment and meditators around the world continue the tradition today. In recent times, sitting has come under attack in slogans such as “Sitting Kills, Moving Heals” and “Sitting is the New Smoking.” What is the evidence against sitting? Are there benefits to sitting? How can we avail ourselves of the benefits and curtail the risks of sitting? Are there healthy ways to sit? The Gokhale Method’s unique perspective on sitting can help you navigate the do’s and don’ts of this ubiquitous activity. In this participatory workshop/presentation expect to shed old ideas, gain new ones, get a posture lift, and enjoy one hour of seated entertainment punctuated by healthy breaks. Esther Gokhale (Go-clay) has been involved in integrative therapies all her life. As a young girl growing up in India, she helped her mother, a nurse, treat abandoned babies waiting to be adopted. This early interest in healing led her to study biochemistry at Harvard and Princeton and, later, acupuncture at the San Francisco School of Oriental Medicine where she became a licensed acupuncturist. After experiencing crippling back pain during her first pregnancy and unsuccessful back surgery, Gokhale began her lifelong crusade to vanquish back pain. Her studies at the Aplomb Institute in Paris and years of research in Brazil, India, Portugal and elsewhere led her to develop the Gokhale Method®, a unique, systematic approach to help people find their bodies’ way back to pain-free living. Gokhale has practiced acupuncture and taught posture, dance and yoga in her Palo Alto wellness center for over twenty years. Her Gokhale Method Foundations course is now taught by qualified teachers all over the world. Their offerings, her book, 8 Steps to a Pain-Free Back, DVD, posture-friendly cushion, and chair are all available on her website at gokhalemethod.com. In May 2013, The New York Times featured Esther in an article giving her the title, “The Posture Guru of Silicon Valley.” Gokhale has been a speaker/teacher at corporations such as Google, IDEO, and Mimosa Systems and conferences including TEDx(Stanford), Ancestral Health Symposium, Western Price Foundation Conference, and PrimalCon. She also speaks with medical physician groups including Stanford, PAMF, UCSF and sports teams such as the trainers of the SF 49ers and several Stanford teams. Her method has been featured in publications including The San Francisco Chronicle, Toronto Sun, Chicago- Sun Times, Prevention Magazine, and AAOS.
Views: 33358 TheIHMC
Dealing with the Emotional Aspects of Cancer - Dr. Manuela Kogon
On September 25, 2010 the Caring for Carcinoid Foundation held its first Neuroendocrine Tumor Patient Education Conference at Stanford University's Alumni Center in Palo Alto California, USA. This day-long event was attended by over 100 patients and caregivers and featured neuroendocrine tumor experts from Stanford University and UCSF Medical Center.
Views: 1564 Caring4Carcinoid
How To Catch Breast Cancer Early: Stanford Doctors Explain Mammography Options
There are several breast cancer detection options, and it is recommended that all women over age 40 get their mammograms. It has been shown that regular screening can catch breast cancer early and save lives. Stanford radiologists Drs. Debra Ikeda and Jafi Lipson explain the different types of imaging available and also explain the newest technology, tomosynthesis, or 3D mammography. Visit: http://stanfordhealthcare.org/bcaware
Views: 39885 Stanford Health Care
Surgical Management of Neuroendocrine Tumors of the GI Tract - Dr. Jeffrey Norton
On September 25, 2010 the Caring for Carcinoid Foundation held its first Neuroendocrine Tumor Patient Education Conference at Stanford University's Alumni Center in Palo Alto California, USA. This day-long event was attended by over 100 patients and caregivers and featured neuroendocrine tumor experts from Stanford University and UCSF Medical Center.
Views: 3152 Caring4Carcinoid
UCSF Weill Institute for Neurosciences Overview
Learn more at https://weill.ucsf.edu
Immunotherapy, a new weapon against cancer
Dr. Jon LaPook introduces us to the next frontier of cancer treatment: immunotherapy, in which the body's own immune system is genetically modified to detect and destroy cancer cells. Subscribe to the "CBS Sunday Morning" Channel HERE: http://bit.ly/20gXwJT Get more of "CBS Sunday Morning" HERE: http://cbsn.ws/1PlMmAz Follow "CBS Sunday Morning" on Instagram HERE: http://bit.ly/23XunIh Like "CBS Sunday Morning" on Facebook HERE: http://on.fb.me/1UUe0pY Follow "CBS Sunday Morning" on Twitter HERE: http://bit.ly/1RquoQb Follow "CBS Sunday Morning" on Google+ HERE: http://bit.ly/1O3jk4x Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B --- "CBS Sunday Morning" features stories on the arts, music, nature, entertainment, sports, history, science, Americana and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.
Views: 3132 CBS Sunday Morning
UCSF Fresno Doctors Academy tour Surgery Department
Community Regional Medical Center staff and surgery faculty at UCSF Fresno recently held an open house for Doctors Academy students at Caruthers, Selma and Sunnyside high schools.
UCSF Researchers Control Embryonic Stem Cells With Light
UC San Francisco researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue. Read more: http://tiny.ucsf.edu/7eHzI7 Director: Arezu Sarvestani Producer: Sara Shaffer PIO: Nicholas Weiler
Joseph DeRisi (UCSF) Part 2: Malaria: Research
https://www.ibiology.org/microbiology/plasmodium-falciparum/#part-2 This brief set of three lectures gives a very general overview of malaria, the disease and Plasmodium falciparum, the causative agent of the most deadly form. Basic research as well as drug development efforts will also be covered in parts two and three of this series.
Views: 5097 iBiology
Technical Tips in Crossing the Occluded Central Vein - UCSF Vascular Symposium 2016
(Visit: http://www.uctv.tv) Robert Kerlan, MD, Professor of Clinical Radiology, UCSF. Recorded on 04/15/2016. Series: "UCSF Vascular Surgery Symposium" [Health and Medicine] [Show ID: 30901]
Quality Talks 2016: Laura Esserman, MD, MBA
Reimagining Cancer Care: Tailored Cancer Care: Less Can Be More Laura Esserman, MD, MBA | Professor, Departments of Surgery and Radiology, and Affiliate Faculty, Institute for Health Policy Studies, University of California San Francisco (UCSF); Director, Carol Franc Buck Breast Care Center and Co-Leader, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center Less is more. That’s the philosophy earning fans (and foes) for Dr. Laura Esserman, director of the University of California—San Francisco’s Carol Franc Buck Breast Care Center. The doctor has long preferred a less-invasive approach when treating the breast condition known as DCIS (ductal carcinoma in situ). Conventional treatment often means biopsy, surgery and radiation. Dr. Esserman favors a lighter touch—see the patient regularly, but hold off on surgery (and its side effects) in cases that aren’t likely to become life-threatening. Recent research indicates outcomes are similar. The doctor—known to sing patients requested songs as they go under anesthesia—is not new to crooning an unconventional tune: she was an early supporter of scaling back cancer screening to reduce overdiagnosis and unnecessary procedures. Again, new research backs her up. Now, she and others are conducting another study to find the best approach for tailored screening. New and novel is becoming familiar refrains for Esserman. Join us in 2017: http://www.qualitytalks.org
Doctor Discusses Possible Brain Cancer Breakthrough
CBS This Morning medical contributor Dr. David Agus talks about a possible breakthrough in cancer treatment, where the poliovirus is being used to as a possible treatment in fighting brain tumors.
Views: 590 CBSDFW